Key result
Sevoflurane anesthesia in healthy humans preserved resting myocardial blood flow (1.05 vs 1.05 mL/min/g; P=0.98) but significantly reduced hyperemic blood flow compared to awake baseline.
Why the study?
Does general anesthesia with sevoflurane alter myocardial blood flow and microcirculatory responses in healthy humans?
Does general anesthesia with sevoflurane alter myocardial blood flow and microcirculatory responses in healthy humans?
Absolute Event Rate: 1.05% vs 1.05%
p-value: p=0.98
Sevoflurane anesthesia preserves resting myocardial blood flow but significantly reduces hyperemic myocardial blood flow and flow reserve in healthy humans.
May warrant caution interpreting flow reserve under sevoflurane; leaves open relevance in patients with coronary disease.
BACKGROUND: Preservation of myocardial perfusion during general anesthesia is likely important in patients at risk for perioperative cardiac complications. Data related to the influence of general anesthesia on the normal myocardial circulation are limited. In this study, we investigated myocardial microcirculatory responses to pharmacological vasodilation and sympathetic stimulation during general anesthesia with sevoflurane in healthy humans immediately before surgical stimulation. METHODS: Six female and 7 male subjects (mean age 43 years, range 28-61) were studied at baseline while awake and during the administration of 1 minimum alveolar concentration sevoflurane. Using myocardial contrast echocardiography, myocardial blood flow (MBF) and microcirculatory variables were assessed at rest, during adenosine-induced hyperemia, and after cold pressor test-induced sympathetic stimulation. MBF was calculated from the relative myocardial blood volume multiplied by its exchange frequency (β) divided by myocardial tissue density (ρT), which was set at 1.05 g·mL(-1). RESULTS: During sevoflurane anesthesia, MBF at rest was similar to baseline values (1.05 ± 0.28 vs 1.05 ± 0.32 mL·min(-1)·g(-1); P = 0.98; 95% confidence interval [CI], -0.18 to 0.18). Myocardial blood volume decreased (P = 0.0044; 95% CI, 0.01-0.04) while its exchange frequency (β) increased under sevoflurane anesthesia when compared with baseline. In contrast, hyperemic MBF was reduced during anesthesia compared with baseline (2.25 ± 0.5 vs 3.53 ± 0.7 mL·min(-1)·g(-1); P = 0.0003; 95% CI, 0.72-1.84). Sympathetic stimulation during sevoflurane anesthesia resulted in a similar MBF compared to baseline (1.53 ± 0.53 and 1.55 ± 0.49 mL·min(-1)·g(-1); P = 0.74; 95% CI, -0.47 to 0.35). CONCLUSIONS: In otherwise healthy subjects who are not subjected to surgical stimulation, MBF at rest and after sympathetic stimulation is preserved during sevoflurane anesthesia despite a decrease in myocardial blood volume. However, sevoflurane anesthesia reduces hyperemic MBF, and thus MBF reserve, in these subjects.
No takes yet. Share an insight, caveat, or question.
Bulte et al. (2013) studied Healthy humans (n=13). Sevoflurane vs. Awake baseline was evaluated on Myocardial blood flow (MBF) at rest (95% CI -0.18 to 0.18, p=0.98). Sevoflurane anesthesia in healthy humans preserved resting myocardial blood flow (1.05 vs 1.05 mL/min/g; P=0.98) but significantly reduced hyperemic blood flow compared to awake baseline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: